Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0986520150150020025
Korean Journal of Endoscrine Surgery
2015 Volume.15 No. 2 p.25 ~ p.33
Prognostic Value of p53 and Cyclin D1 in Papillary Thyroid Carcinoma
Seok Jae-Yeon

Chung Dong-Hae
Chung Yoo-Seung
Ryu Jung-Won
Lee Young-Don
Abstract
Purpose: P53 and cyclin D1 have been evaluated as a prognostic marker in papillary thyroid carcinoma (PTC). However, the relationship between p53/cyclin D1 and PTC prognosis has not yet been confirmed. Therefore, we investigated the relationship between p53/cyclin D1 and PTC prognostic factors.

Methods: 919 patients with PTC were enrolled. Immunohistochemistry slides were reviewed for p53 and cyclin D1 immunoreactivity. Patients were classified into two groups according to the p53 and cyclin D1 grade: negative for ¡Â5% and positive for £¾5%. Medical records were reviewed to evaluate the prognostic factors, lymph node metastatic ratio (LNMR), and MACIS score. We analyzed patients based on p53/cyclin D1(?/?), p53/cyclin D1(?/£«), p53/cyclin D1(£«/?), p53/cyclin D1(£«/£«) separately for evaluation of independent effect of p53 and cyclin D1.

Results: Mean age of the patients was 49.73 years (range 15¡­87), and tumor size was 1.19 cm (range 0.1¡­5.0). P53 was positive in 809 (88.0%) and cyclin D1 was positive in 748 (81.4%). Positivity of p53 and cyclin D1 were correlated (r=0.448). There was no statistical significance in MACIS score. Positivity of p53 and cyclin D1 were related with larger tumor size, older age, early T stage, more tumor capsulation, and female. LNMR was higher in p53/cyclin D1(£«/?) than p53/cyclin D1(?/?) (P=0.036), p53/cyclin D1(?/£«) than p53/cyclin D1(?/?) (P=0.034), and p53/cyclin D1(£«/£«) than p53/cyclin D1(?/?) (P=0.007).
Conclusion: There was no consistent relationship between p53/cyclin D1 and worse prognostic factors of PTC. However, LNMR was higher in p53(£«) and cyclin D1(£«) cases independently, much more in p53/cyclin D1(£«/£«) than p53/cyclin D1(?/?).
KEYWORD
Papillary thyroid carcinoma, p53, Cyclin D1, Prognosis, Lymph node metasta-tic ratio
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) ´ëÇÑÀÇÇÐȸ ȸ¿ø